State Street Corp Arvinas, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Arvinas, Inc. stock. As of the latest transaction made, State Street Corp holds 1,896,190 shares of ARVN stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,896,190

Previous 1,637,050 15.83%

Holding current value

$15.6 Million

Previous $31.4 Million 57.58%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.02 - $20.5 $1.82 Million - $5.31 Million	259,140 Added 15.83%	1,896,190 $13.3 Million
Q4 2024 Feb 14, 2025	SELL	$17.83 - $28.04 $119,050 - $187,223	-6,677 Reduced 0.41%	1,637,050 $31.4 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $1.32 Million - $1.83 Million	-55,961 Reduced 3.29%	1,643,727 $40.5 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $7.77 Million - $12.8 Million	317,521 Added 22.97%	1,699,688 $45.2 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $7.12 Million - $10.2 Million	195,693 Added 16.49%	1,382,167 $57.1 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $383,442 - $1.14 Million	27,022 Added 2.33%	1,186,474 $48.8 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $836,781 - $1.2 Million	42,606 Added 3.81%	1,159,452 $22.8 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $214,018 - $309,554	9,849 Added 0.89%	1,116,846 $27.7 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $960,567 - $1.37 Million	36,733 Added 3.43%	1,106,997 $30.2 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $519,974 - $916,641	-16,014 Reduced 1.47%	1,070,264 $36.6 Million
Q3 2022 Nov 15, 2022	BUY	$41.87 - $57.99 $230,787 - $319,640	5,512 Added 0.51%	1,086,278 $48.3 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $2.14 Million - $4.41 Million	59,396 Added 5.82%	1,080,766 $45.5 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $4.06 Million - $5.5 Million	67,431 Added 7.07%	1,021,370 $68.7 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $2.39 Million - $3.49 Million	36,282 Added 3.95%	953,939 $78.4 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $4.55 Million - $6.71 Million	62,201 Added 7.27%	917,657 $75.4 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $3.21 Million - $4.48 Million	53,122 Added 6.62%	855,456 $65.9 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $2.07 Million - $3.26 Million	35,634 Added 4.65%	802,334 $53 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $2.09 Million - $8.8 Million	103,612 Added 15.63%	766,700 $65.1 Million
Q3 2020 Nov 10, 2020	SELL	$22.99 - $36.34 $883,344 - $1.4 Million	-38,423 Reduced 5.48%	663,088 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $6.83 Million - $13 Million	228,507 Added 48.31%	701,511 $23.5 Million
Q1 2020 May 11, 2020	BUY	$33.0 - $54.5 $15.6 Million - $25.8 Million	473,004 New	473,004 $19.1 Million

Others Institutions Holding ARVN

# of Institutions

245

Shares Held

62.4M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $438M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Arvinas, Inc. Transaction History